The Challenge of Patent Expirations
The Asthma and COPD Drugs market faces a significant challenge from patent expirations of key blockbuster drugs. When a brand-name drug's patent expires, generic manufacturers can produce and market a more affordable version. This can lead to a sharp decline in revenue for the original manufacturer and create intense pricing pressure across the market. While this benefits consumers by lowering costs, it can also impact a company's ability to fund research and development for future innovations. To counter this, pharmaceutical companies are focusing on developing new drug-device combinations, triple therapies, and biologics that are protected by new patents. The constant cycle of patent expiration and innovation is a defining characteristic of the competitive landscape in the Asthma and COPD Drugs Market.